This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of skin of eyelid, including canthus
CD2_INSITU_SKIN_EYELID_EXALLC
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis palpebrae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of eyelid, including canthus
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of eyelid, including canthus
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 65 | 28 | 37 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 75.37 | 75.82 | 75.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 58
- Matched controls
- 581
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
+∞
80.4
57
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
16.4
15
*
L57.0
ICD-10 Finland
Actinic keratosis
15.3
15.3
27
31
TQW99
NOMESCO Finland
Other minor procedure on skin
31.7
13.9
18
8
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
25.3
13.1
18
10
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.0
12
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
39.5
12.4
15
5
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
11.9
11
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
11.9
11
*
CBA10
NOMESCO Finland
Biopsy of eyelid
54.6
11.5
13
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
74.1
11.1
12
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
10.7
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.7
10
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
12.9
10.6
19
21
ZXC15
NOMESCO Finland
Use of photodynamic technique
+∞
9.6
9
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
26.6
8.4
11
5
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
7.4
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.4
7
*
L04AA06
ATC
mycophenolic acid; systemic
+∞
7.4
7
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
30.3
6.4
8
*
127
Kela drug reimbursment
Transplant complication
+∞
6.4
6
*
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
6.4
6
*
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.4
6
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
6.4
6
*
ZXC50
NOMESCO Finland
Cryotherapy
14.7
6.4
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
30
99
4.77
8.74
2.5
1.6
—
—
—
0
0
17
42
5.13
6.85
2.2
1.7
—
—
—
0
0
14
32
5.30
6.11
1.6
1.9
—
—
—
0
0
19
67
3.59
4.71
1.9
1.5
—
—
—
0
0
19
67
3.59
4.71
1.9
1.6
—
—
—
0
0
11
27
4.70
4.36
3.3
1.6
—
—
—
0
0
37
202
2.93
4.33
2.4
2.5
—
—
—
0
0
14
44
3.78
4.05
2.9
4.3
1.54
1.52
mmol/l
0.01
14
39
23
101
2.98
3.94
3.2
2.1
—
—
—
0
0
10
25
4.55
3.86
3.0
6.1
23.90
24.89
mmol/l
—
10
19
38
220
2.75
3.85
2.5
2.1
89.05
90.78
pmol/l
0.09
24
100
39
231
2.72
3.74
8.9
5.0
1.22
1.21
mmol/l
0.09
33
201
30
158
2.67
3.61
2.7
2.1
2.36
2.34
mmol/l
0.38
25
126
7
11
6.97
3.27
1.4
1.5
—
—
—
0
0
7
11
6.97
3.27
1.4
1.5
—
—
—
0
0
33
189
2.52
3.27
4.4
3.7
—
—
—
0
0
57
448
3.21
3.02
31.4
15.9
35.55
23.85
mg/l
1.08
50
360
50
358
2.72
2.96
5.3
4.5
20.16
14.37
mm/h
0.98
44
322
50
363
2.64
2.78
10.8
5.2
81.73
74.85
u/l
1.02
45
336
39
255
2.32
2.73
3.7
2.9
49.50
50.54
u/l
0.04
32
236
18
83
2.62
2.72
4.3
2.7
0.64
0.86
e6/l
0.27
12
44
16
70
2.71
2.67
11.7
5.5
1.13
1.03
mmol/l
0.48
16
60
9
26
3.85
2.59
2.7
1.5
—
—
—
0
0
58
473
3.10
2.56
33.3
18.5
101.66
87.27
umol/l
0.69
58
473
7
18
4.22
2.32
1.0
1.4
—
—
—
0
0
5
9
5.91
2.25
2.0
1.2
—
—
—
0
0
9
30
3.31
2.25
3.1
4.8
24.64
25.19
mmol/l
—
9
30
53
414
2.52
2.22
28.3
15.6
67.52
69.71
ml/min/173m2
0.30
48
338
58
481
2.91
2.22
32.9
19.2
138.93
139.65
mmol/l
1.06
58
465
58
483
2.86
2.22
33.8
19.2
4.00
4.03
mmol/l
0.39
58
465
24
138
2.17
2.19
6.5
3.1
0.12
0.51
e6/l
1.25
19
102
5
10
5.31
2.11
1.4
1.7
—
—
—
0
0
29
182
2.07
2.10
5.7
3.2
—
—
—
0
0
22
128
2.09
1.92
3.2
2.5
394.69
3318.25
umol/l
0.49
16
103
54
436
2.41
1.92
5.6
7.8
39.47
41.91
mmol/mol
0.97
48
397
8
32
2.71
1.66
2.9
5.9
0.29
0.71
%
—
8
32
16
87
2.11
1.64
4.8
2.9
0.50
1.67
e6/l
—
10
47
8
33
2.62
1.60
3.4
5.8
1.41
1.66
%
—
8
33
12
59
2.27
1.55
3.1
5.3
11.80
10.73
kpa
0.46
12
54
12
59
2.27
1.55
3.1
5.3
4.98
5.06
kpa
0.10
12
54
51
419
2.01
1.48
4.7
4.5
1.15
1.23
mmol/l
0.56
45
363
5
16
3.29
1.46
5.2
3.6
—
—
—
0
0
56
480
2.20
1.46
16.7
9.1
21.27
22.70
u/l
0.40
51
458
53
442
2.08
1.46
5.2
5.0
4.10
4.33
mmol/l
1.00
47
393
54
455
2.10
1.42
5.8
5.6
2.29
2.47
mmol/l
0.86
48
396
47
379
1.87
1.41
29.2
16.5
37.96
38.87
%
0.21
28
226
13
76
1.89
1.08
4.7
2.7
19.75
21.49
%
0.25
13
68
23
161
1.66
1.07
2.4
2.1
55.28
58.50
u/l
0.15
18
147
51
437
1.78
1.06
5.3
5.0
1.37
1.43
mmol/l
0.39
45
382
5
22
2.37
1.05
1.0
1.1
—
—
—
0
0
7
37
2.00
0.97
1.7
1.4
—
—
—
0
0
49
420
1.68
0.97
4.6
4.7
1.96
2.00
mu/l
0.09
44
360
11
64
1.87
0.93
2.7
2.4
334.45
210.90
ng/l
0.35
11
57
13
81
1.76
0.89
4.5
2.6
2.22
2.10
g/l
0.37
13
70
10
59
1.82
0.81
5.0
10.1
—
—
—
0
0
7
39
1.89
0.75
6.0
4.7
21.86
24.35
mmol/l
—
7
32
5
26
2.00
0.72
1.2
1.0
—
—
—
0
0
7
42
1.75
0.71
1.1
1.2
—
—
—
0
0
7
42
1.75
0.71
1.1
1.4
—
—
—
0
0
24
189
1.43
0.62
3.5
3.7
5.75
9.50
mg/mmol
0.47
19
113
9
59
1.61
0.58
4.9
4.1
-0.47
1.55
mmol/l
—
9
45
0
16
0.00
0.41
0.0
3.0
—
—
—
0
0
49
454
1.32
0.37
5.9
5.2
6.05
6.15
mmol/l
0.20
43
394
27
233
1.27
0.36
6.1
4.8
32.33
37.14
ng/l
0.28
21
186
16
134
1.26
0.26
5.0
2.8
35.00
30.93
u/l
0.53
16
128
11
89
1.28
0.22
2.6
1.6
29.56
30.44
s
0.27
11
82
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
7
61
1.17
0.18
4.7
3.4
—
—
—
0
0
8
75
1.08
0.08
1.0
1.3
—
37.29
iu/ml
—
0
27
18
190
0.93
0.04
4.5
4.2
—
—
—
0
0
17
162
1.07
0.02
3.8
3.6
22.80
25.20
%
0.28
12
79
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
72.80
—
0
8
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_EYELID_EXALLC – Carcinoma in situ of skin of eyelid, including canthus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).